Paper Review Records
全部论文审稿周期
20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
66
天
Integrative Analysis of Cuproptosis-Related Genes and Repurposable Therapeutic Agents in Type A Aortic Dissection
作者
Chengbin Tang; Yi Dai; Tao Chen; Jun Shao; Tao Zhu; Jingting Ye; Yusheng Shu展开收起
作者单位
1. Northern Jiangsu People’s Hospital Affiliated to Yangzhou University, Yangzhou, China; 2. Department of Center for Cardiac Macrovascular Disease, Northern Jiangsu People’s Hospital, Yangzhou, China; 3. Department of Thoracic Surgery, Northern Jiangsu People’s Hospital, Yangzhou, China展开收起
130
天
Salidroside Alleviates Atherosclerosis by Inhibiting Ferroptosis Through the RAG1/Keap1/Nrf2 Axis
作者
Xiangnan Song; Qing Yang; Jie Yang; Jiali Xu; Yingyu Xiang; Yanhong Liu; Hui Chi展开收起
作者单位
1. Clinical Laboratory Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, China; 2. Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, Harbin, China展开收起
17
天
37
天
Ivabradine Versus Digitalis Glycosides in Heart Failure With Reduced Ejection Fraction: A Comparative Appraisal of Two Additional Medical Therapies
作者
Vittorio Beltrani; Marco Bergonti; Martin R. Gruebler; Giordano M. Pugliesi; Luca Fazzini; Mattia Arrigo; Gregorio Tersalvi展开收起
作者单位
1. Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland; 2. Department of Cardiology, Istituto Cardiocentro Ticino, Lugano, Switzerland; 3. Department of Internal Medicine, Ente Ospedaliero Cantonale, Mendrisio, Switzerland; 4. Department of Cardiology, University Hospital Wiener Neustadt, Danube Private University, Wiener Neustadt, Austria; 5. Department of Internal Medicine, Medical University of Graz, Graz, Austria; 6. Medical Faculty, Sigmund Freud University, Vienna, Austria; 7. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, USA; 8. Non-Invasive Cardiac Imaging Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy; 9. Cardiovascular Department, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy; 10. Department of Internal Medicine, Ente Ospedaliero Cantonale, Lugano, Switzerland展开收起
17
天
Fixed-Dose Combination Versus Add-On Therapy: Clarifying the Role of Cilostazol–Rosuvastatin in Peripheral Artery Disease
作者
Dezheng Lu; Chunyan Kuang展开收起
作者单位
1. Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, China; 2. Department of Cardiology, Guizhou Provincial People’s Hospital, Guiyang, China展开收起
62
天
Organelle Homeostasis and Metabolic Resilience: TFEB at the Crossroads of Lysosomal and Mitochondrial Adaptation
作者
Matthew J. Brody; Nageswara R. Madamanchi展开收起
作者单位
1. Department of Pharmacology, University of Michigan Medical School, Ann Arbor, USA; 2. Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, USA展开收起
FAQ
CARDIOVASCULAR DRUGS AND THERAPY审稿要多久?
截至2026-11-19,CrushSCI 收录了 CARDIOVASCULAR DRUGS AND THERAPY 的 20 篇完整审稿记录。最快一篇从收稿到录用用了 14 天(Rethinking Plaque Stabilization with Evolocumab in Diabetes: Methodological Considerations from the YELLOW III Trial,2026-09-27 收稿,2026-10-11 录用),最慢一篇用了 130 天;平均 51.0 天,中位数 45.5 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
